The ESCMID Study Group for Host and Microbiota Interactions (ESGHAMI) is leading the way in bridging diagnostics, clinical research, and scientific studies across the relatively new field of microbiota research in Europe. The group seeks to understand the clinical significance of host-microbiota associated diseases and health, and explore relevant therapeutic interventions. Their research covers:
How can the gut microbiome be targeted to fight multidrug-resistant organisms?
Davido B, Merrick B, Kuijper E, Benech N, Biehl LM, Corcione S; European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Host and Microbiota Interactions (ESGHAMI). Lancet Microbe. 2025 Aug;6(8):101063
Nonantimicrobial therapies for recurrent urinary tract infection in women: is there a place for faecal microbiota transfer?
Cassir N, Ghani R, Biehl LM, Graells T, Kuijper EJ, Mullish BH, Marchesi JR, Benech N; ESCMID Study Group for Host and Microbiota Interactions (ESGHAMI). Clin Microbiol Infect. 2025 Dec;31(12):1985-1992
MRSA in the community-time to take action.
Goodman AL, Lina G, Kuijper EJ. Clin Microbiol Infect. 2024 Nov 20:S1198-743X(24)00536-6
Update on microbiota-derived therapies for recurrent Clostridioides difficile infections.
Benech N, Barbut F, Fitzpatrick F, Krutova M, Davies K, Druart C, Cordaillat-Simmons M, Heritage J, Guery B, Kuijper E; ESGCD and ESGHAMI. Clin Microbiol Infect. 2024 Apr;30(4):462-468.
Which trial do we need? A sequential multiple assignment randomized trial to determine the optimal Clostridioides difficile treatment sequence.
van Prehn J, van Werkhoven CH, Skinner AM, Guery B, Dubberke ER, Kuijper EJ. Clinical Microbiology and Infection 2024;30(2):165–169.
Bacteriophage therapy in humans.
Nir-Paz R, Kuijper EJ. Clin Microbiol Infect. 2023;29(6):679–681.
Update on Microbiota-derived therapies for recurrent Clostridioides difficile infections, 2023.
Benech N, Barbut N, Fitzpatrick F, Krutova M, Davies K, Druart C, Cordaillat-Simmons M, hHeritage J, Guery B, Kuijper E. Clinical Microbiology and Infection. 2023:S1198-743X(23)00597-9.
Faecal microbiota transplantation for first and second episodes of Clostridioides difficile infection.
van Prehn J, Fitzpatrick F, Kuijper EJ. Lancet Gastroenterol Hepatol. 2022;7(12):1083–1091.
If you have questions or comments for our study group, we warmly invite you to contact us!